LINADIB 5 MG COM REV CT BL AL AL X 10
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1023512590014 -
GGREM
541820080137607 -
Código de barras
7896004772370 -
Código de barras
7896004787510
O que a fonte publica
- Detentor do registro
- EMS S/A
- Princípios ativos
- LINAGLIPTINA
- Embalagem
- 5 MG COM REV CT BL AL AL X 10
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "LINADIB 5 MG COM REV CT BL AL AL X 10",
"holder": "EMS S/A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896004772370",
"7896004787510"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "541820080137607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "57.507.378/0003-65",
"priceRegime": "Regulado",
"productName": "LINADIB",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "5 MG COM REV CT BL AL AL X 10",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "68.35",
"icms-12": "77.67",
"icms-17": "82.35",
"icms-18": "83.35",
"icms-19": "84.38",
"icms-20": "85.44",
"icms-21": "86.52",
"icms-22": "87.63",
"icms-23": "88.77",
"icms-17.5": "82.85",
"icms-19.5": "84.91",
"icms-20.5": "85.97",
"icms-22.5": "88.19",
"icms-12-alc": "69.35",
"icms-17-alc": "73.53",
"icms-18-alc": "74.42",
"icms-19-alc": "75.34",
"icms-20-alc": "76.28",
"icms-21-alc": "77.25",
"icms-22-alc": "78.24",
"icms-23-alc": "79.26",
"withoutTaxes": "61.03",
"icms-17.5-alc": "73.97",
"icms-19.5-alc": "75.81",
"icms-20.5-alc": "76.76",
"icms-22.5-alc": "78.74"
},
"pisCofinsList": "Negativa",
"substanceText": "LINAGLIPTINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "91.69",
"icms-12": "104.19",
"icms-17": "110.47",
"icms-18": "111.81",
"icms-19": "113.19",
"icms-20": "114.61",
"icms-21": "116.06",
"icms-22": "117.55",
"icms-23": "119.08",
"icms-17.5": "111.14",
"icms-19.5": "113.90",
"icms-20.5": "115.33",
"icms-22.5": "118.30",
"icms-12-alc": "95.87",
"icms-17-alc": "101.65",
"icms-18-alc": "102.88",
"icms-19-alc": "104.15",
"icms-20-alc": "105.45",
"icms-21-alc": "106.79",
"icms-22-alc": "108.16",
"icms-23-alc": "109.57",
"withoutTaxes": "84.37",
"icms-17.5-alc": "102.26",
"icms-19.5-alc": "104.80",
"icms-20.5-alc": "106.12",
"icms-22.5-alc": "108.85"
},
"invalidBarcodes": [],
"activeSubstances": [
"LINAGLIPTINA"
],
"therapeuticClass": "A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1023512590014",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10N1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:541820080137607"